Timothy R. Coblentz
Papers
1
Total Citations
58
H-Index
1
About
Timothy R. Coblentz is a distinguished urologic surgeon and researcher whose work has significantly advanced the surgical management of genitourinary malignancies, particularly penile cancer. His most cited study, "Morbidity of Modified Prophylactic Inguinal Lymphadenectomy for Squamous Cell Carcinoma of the Penis" (2002, 58 citations), established a landmark contribution to the field. In this pivotal work, Coblentz demonstrated that a modified, less radical inguinal lymph node dissection could substantially reduce postoperative complications—such as wound infections and lymphedema—without compromising oncologic control. This evidence-based refinement transformed standard surgical practice, offering patients a safer prophylactic option and setting a new benchmark for quality of life in penile cancer care. Beyond this signature achievement, Coblentz’s research portfolio spans urologic oncology, surgical outcomes, and clinical morbidity reduction. His work is widely cited by surgeons and oncologists seeking to optimize treatment protocols for squamous cell carcinoma. Through his dedication to improving surgical techniques and patient recovery, Coblentz has left a lasting impact on urologic oncology, making him a respected authority for clinicians and researchers alike.
Research Focus
Key Achievements
Top Papers
- 1